The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

被引:87
|
作者
Forrest, DM
Seminari, E
Hogg, RS
Yip, B
Raboud, J
Lawson, L
Phillips, P
Schechter, MT
O'Shaughnessy, MV
Montaner, JSG
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Fac Med, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
[5] Canadian HIV Trials Network, Vancouver, BC, Canada
[6] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
关键词
D O I
10.1086/515030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The incidence and spectrum of primary AIDS-defining illnesses in human immunodeficiency virus-positive patients receiving antiretroviral drugs may have changed since the introduction of newer antiretroviral agents. We performed a retrospective analysis of patients enrolled in the British Columbia Drug Treatment Program who were ever prescribed antiretroviral drugs between 1 January 1994 and 31 December 1996. Rates were calculated on a 6-month basis. There were 344 AIDS cases diagnosed among 2,533 participants between 1994 and 1996. The incidence of primary AIDS diseases decreased from 1994 to 1996, with a sharp decline in 1995 and 1996. There was no statistically significant change in the incidence of primary AIDS diagnoses relative to one another, and Pneumocystis carinii pneumonia and Kaposi's sarcoma remain the most common AIDS index diagnoses. In patients receiving antiretroviral therapy in the modern era, the incidence of AIDS-defining illnesses has decreased substantially, but the spectrum of AIDS-defining illnesses remains unchanged.
引用
收藏
页码:1379 / 1385
页数:7
相关论文
共 50 条
  • [1] Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs
    Michaels, SH
    Clark, R
    Kissinger, P
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 468 - 469
  • [2] Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
    Brodt, HR
    Kamps, BS
    Gute, P
    Knupp, B
    Staszewski, S
    Helm, EB
    [J]. AIDS, 1997, 11 (14) : 1731 - 1738
  • [3] Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
    Caniglia, Ellen C.
    Cain, Lauren E.
    Justice, Amy
    Tate, Janet
    Logan, Roger
    Sabin, Caroline
    Winston, Alan
    van Sighem, Ard
    Miro, Jose M.
    Podzamczer, Daniel
    Olson, Ashley
    Ramon Arribas, Jose
    Moreno, Santiago
    Meyer, Laurence
    del Romero, Jorge
    Dabis, Francois
    Bucher, Heiner C.
    Wandeler, Gilles
    Vourli, Georgia
    Skoutelis, Athanasios
    Lanoy, Emilie
    Gasnault, Jacques
    Costagliola, Dominique
    Hernan, Miguel A.
    [J]. NEUROLOGY, 2014, 83 (02) : 134 - 141
  • [4] ANTIRETROVIRAL PENETRATION INTO THE CNS AND INCIDENCE OF AIDS-DEFINING NEUROLOGIC CONDITIONS
    Beardsley, Justin
    Le, Thuy
    [J]. NEUROLOGY, 2015, 84 (06) : 632 - 633
  • [5] Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy
    Toh, Han-Siong
    Yang, Chun-Ting
    Yang, Kai-Li
    Ku, Han-Chang
    Liao, Chia-Te
    Kuo, Shihchen
    Tang, Hung-Jen
    Ko, Wen-Chien
    Ou, Huang-Tz
    Ko, Nai-Ying
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 91 : 44 - 49
  • [6] Effectiveness of combined antiretroviral therapy on multiple aids-defining illnesses in an hiv seroconverter cohort
    Ferreros, Inmaculada
    Hurtado, Isabel
    del Amo, Julia
    Muga, Roberto
    del Romero, Jorge
    Garcia, Patricia
    Alastrue, Ignacio
    Belda, Josefina
    Guevara, Marcela
    Perez, Santiago
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (03): : 179 - 184
  • [7] Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
    Monforte, AD
    Duca, PG
    Vago, L
    Grassi, MP
    Moroni, M
    [J]. NEUROLOGY, 2000, 54 (09) : 1856 - 1859
  • [8] The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection
    Mocroft, A
    Youle, M
    Phillips, AN
    Halai, R
    Easterbrook, P
    Johnson, MA
    Gazzard, B
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (05) : 491 - 497
  • [9] Antiretroviral combination therapies and AIDS-defining cancers
    Serraino, D
    Pezzotti, P
    Boros, S
    Rezza, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (01) : 84 - 86
  • [10] Incidence of AIDS-defining opportunistic illnesses in the US may be leveling from 1998 to 1999
    McNaghten, AD
    Hanson, DL
    Nakashima, AK
    Swerdlow, DL
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1216 - 1216